The Research Executive Agency is a funding body created by the European Commission to foster excellence in research and innovation. It manages large parts of the Seventh Framework Programme for Research, Technological Development and Demonstration Activities (FP7), the main EU funding package to respond to Europe’s needs in terms of jobs and competitiveness in the global knowledge economy.
With effect from 1 January 2014, the Trans-European Transport Network Executive Agency (TEN-T EA), which was set up by the European Commission in 2006 to manage the technical and financial implementation of its TEN-T programme, has become the Innovation and Networks Executive Agency (INEA). INEA’s mission is to implement parts of the EU programmes: Connecting Europe Facility (CEF), Horizon 2020 and the legacy programmes: TEN-T and Marco Polo 2007-2013.
A refinement of scope has become effective for the Executive Agency for Competitiveness and Innovation, which, with effect from 1 January 2014, is now called Executive Agency for Small and Medium-sized enterprises (EASME).
The Agency’s mandate covers a variety of Europe and worldwide opportunities for organisations, professionals and individuals. Seven key Community programmes have been partly or fully delegated to the EACEA: Lifelong Learning, Erasmus Mundus, Tempus, Culture, Youth in Action, Europe for Citizens and Media, and several international Cooperation Agreements in the field of higher education. The Centre reviewed the existing terminological resources in the fields of activity of EACEA, the ETF and CEDEFOP, and a joint terminology project was included in the plan for 2010.
The Council is the main decision-making body of the European Union. The Council is responsible for decision-making and co-ordination. The acts of the Council can take the form of regulations, directives, decisions, common actions or common positions, recommendations or opinions. The Council can also adopt conclusions, declarations or resolutions.
On 8 December, the Centre signed an agreement with the Single Resolution Board (SRB). Based in Brussels, this newly-created EU agency has been operational as of 1 January 2015.
The IMI is a unique partnership between the European Community and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The aim of IMI is to support the faster discovery and development of better medicines for patients and to enhance Europe’s competitiveness by ensuring that its biopharmaceutical sector remains a dynamic high-technology sector.
The Fuel Cells and Hydrogen Joint Undertaking is a unique public private partnership supporting research, technological development and demonstration (RTD) activities in fuel cell and hydrogen energy technologies in Europe. Its aim is to accelerate the market introduction of these technologies, realising their potential as an instrument in achieving a carbon-lean energy system.
The EDPS’ general objective is to ensure that the EU institutions and bodies respect the right to privacy when they process personal data and develop new policies.
On 6 May 2014, the Council of the European Union adopted the Regulation establishing the ECSEL Joint Undertaking. This new organisation replaces ARTEMIS JU and ENIAC JU. ECSEL JU has become operational as of 27 June 2014.